Xvivo Perfusion INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$128Kgeneral payments (2019-2025)
$69Kresearch payments (2019-2025)
207clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $8,087
2023 $30K
2024 $52K
2025 $38K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Thoracic Surgery (Cardiothoracic Vascular Surgery) $45K
Surgery $11K
Transplant Surgery $9,799
Pulmonary Disease $8,819
Vascular Surgery $5,516
Advanced Heart Failure and Transplant Cardiology $3,896

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Toshihiro Okamoto Cleveland, OH $35,572.32
Stephanie Chang New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,239.94
Ezequiel Molina Atlanta, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,000.00
Mindaugas Rackauskas Gainesville, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,887.62
Jorge Mallea Jacksonville, FL Pulmonary Disease $3,121.82
Leonardo Paim Nicolau Da Costa Tampa, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,019.02
James Kirklin Birmingham, AL Vascular Surgery $3,000.00
David Mcgiffin Birmingham, AL Vascular Surgery $2,500.00
Joseph Costa Yonkers, NY Physician Assistant $2,443.09
Farooq Sheikh Washington, DC Advanced Heart Failure and Transplant Cardiology $2,250.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.